-

EMA announcement positive CHMP opinion for Biogen Tofersen (Qualsody)
23 February 2024 New treatment for rare motor neurone disease recommended for approval EMA has recommended granting a marketing authorisation in the European Union for a new therapy for the… More >>
-
EUpALS in Lancet Neurology editorial November 2023
Speeding up research to improve the lives of people with ALS Advances in research over the past few years have provided a greater understanding of the pathophysiology, genetics, and risk… More >>



















